Advertisement

Current Radiology Reports

, 6:30 | Cite as

Vertebroplasty in Elderly Patients: A Clinical Effectiveness Analysis

  • Michelangelo Nasuto
  • Michele Falcone
  • Vincenzo Strizzi
  • Lucia Florio
  • Walter Lauriola
  • Giovanni Ciccarese
  • Giuseppe Guglielmi
  • Francesco Florio
Geriatrics (G Guglielmi, Section Editor)
  • 10 Downloads
Part of the following topical collections:
  1. Geriatrics

Abstract

Purpose of Review

Minimally invasive vertebral augmentation procedures (VAP) have been first introduced to provide pain relief in patients with osteoporotic vertebral fractures (VF). However, in the last decade scientific literature revealed to be quite controversial about their efficacy. The aim of this review was to analyze clinical evidences from current literature, supported by our own experience.

Recent Findings

Compared to conservative therapies, VAP represent an effective treatment for recent VF and, in elderly patients, reduce mortality and morbidity. Advances in technology have widened the fields of application towards other spine pathologies typical of elderly, such as primary and metastatic tumors.

Summary

In patients with severe pain for recent or un-healed vertebral fracture, VAP are clinically more effective than conservative treatment. Accurate pain assessment and pre-procedural Magnetic Resonance Imaging are highly recommended to obtain optimal patient selection and best treatment results.

Keywords

Percutaneous vertebroplasty Kyphoplasty Vertebral augmentation procedures Vertebral fractures Mini-invasive treatment Aging spine Vertebral fractures management 

Notes

Compliance with Ethical Guidelines

Conflict of interest

Michelangelo Nasuto, Michele Falcone, Vincenzo Strizzi, Lucia Florio, Walter Lauriola, Giovanni Ciccarese, and Francesco Florio each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Recently published papers of particular interest have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Kanis J; On behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level: technical report. World Health Organization Collaborating Centre for metabolic bone diseases. University of Sheffield, Sheffield; 2008.Google Scholar
  2. 2.
    Katzman WB, Wanek L, Shepherd JA, Sellmeyer DE. Age related hyperkyphosis: its causes, consequences, and management. J Orthop Sports Phys Ther. 2010;40:352–60.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    • Borgström F, Beall DP, Berven S, Boonen S, Christie S, Kallmes DF, et al. Health economic aspects of vertebral augmentation procedures. Osteoporos Int. 2015;26(4):1239–49.  https://doi.org/10.1007/s00198-014-2953-5. A comprehensive health economic analysis on VAP.
  4. 4.
    Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285:320–3.  https://doi.org/10.1001/jama.285.3.320.CrossRefPubMedGoogle Scholar
  5. 5.
    Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008;22:671–8.  https://doi.org/10.1016/j.beem.2008.06.001.CrossRefPubMedGoogle Scholar
  6. 6.
    Ensrud KE, Schousboe JT. Clinical practice. Vertebral fractures. N Engl J Med. 2011;364(17):1634–42.CrossRefPubMedGoogle Scholar
  7. 7.
    Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–33.CrossRefPubMedGoogle Scholar
  8. 8.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–75.CrossRefPubMedGoogle Scholar
  9. 9.
    Cooper C. Epidemiology and public health impact of osteoporosis. Baillieres Clin Rheumatol. 1993;7(3):459–77.CrossRefPubMedGoogle Scholar
  10. 10.
    Kondo KL. Osteoporotic vertebral compression fractures and vertebral augmentation. Semin Intervent Radiol. 2008;25:413–24.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Beall DP, Olan WJ, Kakad P, Li Q, Hornberger J. Economic analysis of kiva VCF treatment system compared to balloon kyphoplasty using randomized kiva safety and effectiveness trial (KAST) data. Pain Phys. 2015;18(3):E299–306.Google Scholar
  12. 12.
    Goldstein CL, Chutkan NB, Choma TJ, Orr RD. Management of the elderly with vertebral compression fractures. Neurosurgery. 2015;77(Suppl 4):S33–45.CrossRefPubMedGoogle Scholar
  13. 13.
    Galibert P, Deramond H, Rosat P, Le Gars D. Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty. Neurochirurgie. 1987;33:166–8.PubMedGoogle Scholar
  14. 14.
    Kim DH, Vaccaro AR. Osteoporotic compression fractures of the spine: current options and considerations for treatment. Spine J. 2006;6(5):479–87.CrossRefPubMedGoogle Scholar
  15. 15.
    • Stevenson M, Gomersall T, Lloyd Jones M, Rawdin A, Hernández M, Dias S, et al. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2014;18(17):1–290.  https://doi.org/10.3310/hta18170. Good review about cost-effectiveness analysis of VAP.
  16. 16.
    Sun H, Lu PP, Liu YJ, Yang X, Zhou PH, Shen XF, et al. Can unilateral kyphoplasty replace bilateral kyphoplasty in treatment of osteoporotic vertebral compression fractures? A systematic review and meta-analysis. Pain Phys. 2016;19(8):551–63.Google Scholar
  17. 17.
    •• Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009;361:557–68.  https://doi.org/10.1056/nejmoa0900429. One of the two “sham” trials confuting the effectiveness of the VAP. Despite numerous controversial aspects on study design, these articles led to a steep decrease in number of VAP during the 5-years period subsequent to their publication.
  18. 18.
    •• Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009;361:569–79.  https://doi.org/10.1056/nejmoa0900563. One of the two “sham” trials confuting the effectiveness of the VAP. Despite numerous controversial aspects on study design, these articles led to a steep decrease in number of VAP during the 5-years period subsequent to their publication.
  19. 19.
    Flug J, Hanford A, Ortiz O. Vertebral augmentation versus conservative therapy for emergently admitted vertebral compression deformities: an economic analysis. Pain Phys. 2013;16:441–5.Google Scholar
  20. 20.
    Ong KL, Lau E, Kemner JE, Kurz SM. Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading? Osteoporos Int. 2013;24:1437.  https://doi.org/10.1007/s00198-012-2100-0.CrossRefPubMedGoogle Scholar
  21. 21.
    Zhang Y, Shi L, Tang P, Zhang L. Comparison of the efficacy between two micro-operative therapies of old patients with osteoporotic vertebral compression fracture: a network meta-analysis. J Cell Biochem. 2017;118(10):3205–12.CrossRefPubMedGoogle Scholar
  22. 22.
    Martelli N, Devaux C, van den Brink H, Pineau J, Prognon P, Borget I. A systematic review of the level of evidence in economic evaluations of medical devices: the example of vertebroplasty and kyphoplasty. PLoS ONE. 2015;10(12):e0144892.  https://doi.org/10.1371/journal.pone.0144892.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    •• Clark W, Bird P, Gonski P, Diamond TH, Smerdely P, McNeil HP, et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2016;388(10052):1408–16.  https://doi.org/10.1016/s0140-6736(16)31341-1. Recent article with a solid study design outlining the effectiveness of vertebroplasty in acute vertebral fractures.
  24. 24.
    Kasperk C, Grafe IA, Schmitt S, Nöldge G, Weiss C, Da Fonseca K, et al. Three-year outcomes after kyphoplasty in patients with osteoporosis with painful vertebral fractures. J Vasc Interv Radiol. 2010;21:701–9.  https://doi.org/10.1016/j.jvir.2010.01.003.CrossRefPubMedGoogle Scholar
  25. 25.
    Blattert TR, Jestaedt L, Weckbach A. Suitability of a calcium phosphate cement in osteoporotic vertebral body fracture augmentation: a controlled, randomized, clinical trial of balloon kyphoplasty comparing calcium phosphate versus polymethylmethacrylate. Spine. 2009;34:108–14.  https://doi.org/10.1097/BRS.0b013e31818f8bc1.CrossRefPubMedGoogle Scholar
  26. 26.
    Hargunani R, Le Corroller T, Khashoggi K, Murphy KJ, Munk PL. Percutaneous vertebral augmentation: the status of vertebroplasty and current controversies. Semin Musculoskelet Radiol. 2011;15:117–24.  https://doi.org/10.1055/s-0031-1275594.CrossRefPubMedGoogle Scholar
  27. 27.
    Grafe IA, Baier M, Nöldge G, Weiss C, Da Fonseca K, Hillmeier J, et al. Calcium-phosphate and polymethylmethacrylate cement in long-term outcome after kyphoplasty of painful osteoporotic vertebral fractures. Spine. 2008;33:1284–90.  https://doi.org/10.1097/BRS.0b013e3181714a84.CrossRefPubMedGoogle Scholar
  28. 28.
    Mailli L, Filippiadis DK, Brountzos EN, Alexopoulou E, Kelekis N, Kelekis A. Clinical outcome and safety of multilevel vertebroplasty: clinical experience and results. Cardiovasc Intervent Radiol. 2013;36:183–91.  https://doi.org/10.1007/s00270-012-0379-z.CrossRefPubMedGoogle Scholar
  29. 29.
    Xiao H, Yang J, Feng X, et al. Comparing complications of vertebroplasty and kyphoplasty for treating osteoporotic vertebral compression fractures: a meta-analysis of the randomized and non-randomized controlled studies. Eur J Orthop Surg Traumatol. 2015;25(1):77.  https://doi.org/10.1007/s00590-014-1502-4.CrossRefGoogle Scholar
  30. 30.
    Tanigawa N, Kariya S, Komemushi A, Tokuda T, Nakatani M, Yagi R, et al. Cement leakage in percutaneous vertebroplasty for osteoporotic compression fractures with or without intravertebral clefts. AJR Am J Roentgenol. 2009;193(5):W442–5.  https://doi.org/10.2214/AJR.09.2774.CrossRefPubMedGoogle Scholar
  31. 31.
    Semaan H, Obri T, Bazerbashi M, Paull D, Liu X, Sarrouj M, et al. Clinical outcome and subsequent sequelae of cement extravasation after percutaneous kyphoplasty and vertebroplasty: a comparative review. Acta Radiol. 2017.  https://doi.org/10.1177/0284185117732599.PubMedGoogle Scholar
  32. 32.
    Choe DH, Marom EM, Ahrar K, Truong MT, Madewell JE. Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty. AJR. 2004;183:1097–102.  https://doi.org/10.2214/ajr.183.4.1831097.CrossRefPubMedGoogle Scholar
  33. 33.
    Yen CH, Teng MMH, Yuan WH, Sun YC, Chang CY. Preventive vertebroplasty for adjacent vertebral bodies: a good solution to reduce adjacent vertebral fracture after percutaneous vertebroplasty. AJNR Am J Neuroradiol. 2012;33:826–32.  https://doi.org/10.3174/ajnr.A2898.CrossRefPubMedGoogle Scholar
  34. 34.
    Diel P, Freiburghaus L, Roder C, Benneker LM, Popp A, Perler G, et al. Safety, effectiveness and predictors for early reoperation in therapeutic and prophylactic vertebroplasty: short-term results of a prospective case series of patients with osteoporotic vertebral fractures. Eur Spine J. 2012;21:S792–9.  https://doi.org/10.1007/s00586-011-1989-x.CrossRefPubMedGoogle Scholar
  35. 35.
    • Song D, Meng B, Gan M, Niu J, Li S, Chen H, et al. The incidence of secondary vertebral fracture of vertebral augmentation techniques versus conservative treatment for painful osteoporotic vertebral fractures: a systematic review and meta-analysis. Acta Radiol. 2015;56(8):970–9.  https://doi.org/10.1177/0284185114544240. A systematic review and meta-analysis studying the possible association of VAP with the incidence of new vertebral fractures.
  36. 36.
    • Zhang H, Xu C, Zhang T, Gao Z, Zhang T. Does percutaneous vertebroplasty or balloon kyphoplasty for osteoporotic vertebral compression fractures increase the incidence of new vertebral fractures? A meta-analysis. Pain Phys. 2017;20(1):E13–E28. Recent meta-analysis about the possible association of VAP with the onset of new vertebral fractures.Google Scholar
  37. 37.
    • Klazen CA, Venmans A, de Vries J, van Rooij WJ, Jansen FH, Blonk MC, et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II. AJNR Am J Neuroradiol. 2010;31:1447–50.  https://doi.org/10.3174/ajnr.a2148. A significant article studying the possible association of VAP with the onset of new vertebral fractures.
  38. 38.
    Magerl F, Aebi M, Gertzbein SD, Harms J, Nazarian S. A comprehensive classification of thoracic and lumbar injuries. Eur Spine J. 1994;3:184–201.CrossRefPubMedGoogle Scholar
  39. 39.
    Benz BK, Gemery JM, McIntyre JJ, Eskey CJ. Value of immediate preprocedure magnetic resonance imaging in patients scheduled to undergo vertebroplasty or kyphoplasty. Spine (Phila Pa 1976). 2009;34:609–12.  https://doi.org/10.1097/brs.0b013e31819740bb.CrossRefGoogle Scholar
  40. 40.
    Guarnieri G, Vassallo P, Ambrosanio G, Zecolini F, Lavanga A, Varelli C, et al. Vertebroplasty as a treatment for primary benign or metastatic cervical spine lesions: up to one year of follow-up. Neuroradiol J. 2010;23:90–4.  https://doi.org/10.1177/197140091002300115.CrossRefPubMedGoogle Scholar
  41. 41.
    •• Barr JD, Jensen ME, Hirsch JA, McGraw JK, Barr RM, Brook AL, et al. Position statement on percutaneous vertebral augmentation: a consensus statement developed by the Society of Interventional Radiology (SIR), American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS), American College of Radiology (ACR), American Society of Neuroradiology (ASNR), American Society of Spine Radiology (ASSR), Canadian Interventional Radiology Association (CIRA), and the Society of NeuroInterventional Surgery (SNIS). J Vasc Interv Radiol. 2014;25:171–81.  https://doi.org/10.1016/j.jvir.2013.10.001. A consensus statement on VAP developed by several scientific societies in 2014.
  42. 42.
    Liu JT, Liao WJ, Tan WC, et al. Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporos Int. 2010;21:359–64.CrossRefPubMedGoogle Scholar
  43. 43.
    Evans AJ, Kip KE, Brinjikji W, et al. Randomized controlled trial of vertebroplasty versus kyphoplasty in the treatment of vertebral compression fractures. J Neurointerv Surg. 2016;8(7):756–63.CrossRefPubMedGoogle Scholar
  44. 44.
    Dohm M, Black CM, Dacre A, Tillman JB, Fueredi G. A randomized trial comparing balloon kyphoplasty and vertebroplasty for vertebral compression fractures due to osteoporosis. Am J Neuroradiol. 2014;35:2227–36.CrossRefPubMedGoogle Scholar
  45. 45.
    • Gu CN, Brinjikji W, Evans AJ, Murad MH, Kallmes DF. Outcomes of vertebroplasty compared with kyphoplasty: a systematic review and meta-analysis. J Neurointerv Surg. 2016;8:636–42. A comprehensive meta-analysis comparing the outcomes of vertebroplasty and kyphoplasty.Google Scholar
  46. 46.
    Premat K, Clarencon F, Cormier E, Mahtout J, Bonaccorsi R, Degos V, Chiras J. Long-term outcome of percutaneous alcohol embolization combined with percutaneous vertebroplasty in aggressive vertebral hemangiomas with epidural extension. Eur Radiol. 2017;27(7):2860–7.CrossRefPubMedGoogle Scholar
  47. 47.
    McDonald RJ, McDonald JS, Kallmes DF, et al. Effect of systemic therapies on outcomes following vertebroplasty among patients with multiple myeloma. AJNR Am J Neuroradiol. 2016;37(12):2400–6.CrossRefPubMedGoogle Scholar
  48. 48.
    Rousing R, Hansen KL, Andersen MO, Jespersen SM, Thomsen K, Lauritsen JM. Twelve-months follow-up in forty-nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine. 2010;35:478–82.  https://doi.org/10.1097/BRS.0b013e3181b71bd1.CrossRefPubMedGoogle Scholar
  49. 49.
    •• Wardlaw D, Cummings SR, Van Meirhaeghe J, Bastian L, Tillman JB, Ranstam J, Eastell R, Shabe P, Talmadge K, Boonen S. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009;373:1016–24.  https://doi.org/10.1016/s0140-6736(09)60010-6. An important trial on the safety and efficacy of kyphoplasty compared with conservative treatment.
  50. 50.
    American Academy of Orhopaedic Surgeons. The treatment of symptomatic osteoporotic spinal compression fractures: guideline and evidence report; 2010. http://www.aaos.org/research/guidelines/SCFguideline.pdf.
  51. 51.
    •• Klazen CA, Lohle PN, de Vries J et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (VERTOS II): an open-label randomised trial. Lancet. 2010;376:1085–92. An important trial on the safety and efficacy of vertebroplasty compared to conservative treatment.Google Scholar
  52. 52.
    • Rosenbaum BP, Kshettry VR, Kelly ML, Mroz TE, Weil RJ. Trends in inpatient vertebroplasty and kyphoplasty volume in the United States, 2005–2011: assessing the impact of randomized controlled trials. Clin Spine Surg. 2017;30(3):E276–E282.  https://doi.org/10.1097/bsd.0000000000000207. This article analyzed the impact of published works on VAP in USA during the 6-years period from 2005 to 2011.
  53. 53.
    • Ong KL, Beall DP, Frohbergh M, Lau E, Hirsch JA. Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? Osteoporos Int. 2017;24:1–9.  https://doi.org/10.1007/s00198-017-4281-z. An interesting article focused on the impact of the "sham" trials published on NEJM in 2009.
  54. 54.
    Lehman VT, Wood CP, Hunt CH, Carter RE, Allred JB, Diehn FE, Morris JM, Wald JT, Thielen KR. Facet joint signal change on MRI at levels of acute/subacute lumbar compression fractures. AJNR Am J Neuroradiol. 2013;34:1468–73.  https://doi.org/10.3174/ajnr.a3449.CrossRefPubMedGoogle Scholar
  55. 55.
    Fritzell P, Ohlin A, Borgstrom F. Cost-effectiveness of balloon kyphoplasty versus standard medical treatment in patients with osteoporotic vertebral compression fracture: a Swedish multicenter randomized controlled trial with 2-year follow-up. Spine. 2011;36:2243–51.CrossRefPubMedGoogle Scholar
  56. 56.
    Svedbom A, Alvares L, Cooper C, Marsh D, Strom O. Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis. Osteoporos Int. 2013;24(1):355–67.CrossRefPubMedGoogle Scholar
  57. 57.
    Ström O, Leonard C, Marsh D, Cooper C. Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting. Osteoporos Int. 2010;21:1599–608.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Michelangelo Nasuto
    • 1
  • Michele Falcone
    • 1
  • Vincenzo Strizzi
    • 1
  • Lucia Florio
    • 2
  • Walter Lauriola
    • 1
  • Giovanni Ciccarese
    • 1
  • Giuseppe Guglielmi
    • 3
    • 4
  • Francesco Florio
    • 1
  1. 1.Interventional Radiology Unit, Department of Cardiovascular DiseaseIRCCS Hospital “Casa Sollievo della Sofferenza”San Giovanni RotondoItaly
  2. 2.Neurology Unit, Department of Medical SciencesIRCCS Hospital “Casa Sollievo della Sofferenza”San Giovanni RotondoItaly
  3. 3.Department of RadiologyScientific Institute Hospital “Casa Sollievo della Sofferenza”San Giovanni RotondoItaly
  4. 4.Department of Clinical and Experimental MedicineFoggia University School of MedicineFoggiaItaly

Personalised recommendations